These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 13853881

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
    HINZ CF, WEDGWOOD RJ, PILLEMER L.
    J Lab Clin Med; 1961 Feb; 57():185-98. PubMed ID: 13714488
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Validity and limitations in the determination of serum properdin by means of zymosan].
    ZANUSSI C, TASCHINI P, SELVA G, ORTOLANI C.
    Boll Ist Sieroter Milan; 1958 Feb; 37(5-6):237-45. PubMed ID: 13560652
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A NEW METHOD FOR THE STUDY OF CYTOTOXIC SYSTEMS (SPECIFIC EVEN NON-SPECIFIC) OF BLOOD SERUMS.
    RYBAK M, PETAKOVA M, SIMONIANOVA E.
    Z Immunitats Allergieforsch; 1963 Oct; 125():351-7. PubMed ID: 14117569
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [The properdin system. Part 1. A modified method for determination of properdin in the serum].
    MAASSEN W.
    Z Immun exp ther; 1960 May; 119():405-14. PubMed ID: 14419242
    [No Abstract] [Full Text] [Related]

  • 32. Quantitative studies of the properdin-complement system. III. Kinetics of the reaction between C'3 and the properdin-zymosan complex.
    LEON MA.
    J Immunol; 1958 Jul; 81(1):23-8. PubMed ID: 13563875
    [No Abstract] [Full Text] [Related]

  • 33. [Bactericidal activity of normal and low-properdin sera and of properdin-zymosan complexes].
    SZEMERE G.
    Kiserl Orvostud; 1963 Feb; 15():58-61. PubMed ID: 13979914
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [EFFECT OF ZYMOSAN AND ITS FRACTIONS ON THE PROPERDIN LEVEL IN THE BLOOD AND ON THE MORPHOLOGY OF ORGANS AND TISSUES].
    RUTBERG RA, LOSEVA GI, NEMONOVA NM, MALANINA VN.
    Biull Eksp Biol Med; 1964 Apr; 13():127-32. PubMed ID: 14248407
    [No Abstract] [Full Text] [Related]

  • 36. The properdin system and immunity. III. The zymosan assay of properdin.
    PILLEMER L, BLUM L, LEPOW IH, WURZ L, TODD EW.
    J Exp Med; 1956 Jan 01; 103(1):1-13. PubMed ID: 13278451
    [Abstract] [Full Text] [Related]

  • 37. Further studies on cytolysis of Ehrlich ascites tumor cells brought into contact with normal human serum. The nature of the heat-labile factor.
    TOKUNAGA A, OKAMURA J, KOSAKI G, KURU M.
    Gan; 1962 Jun 01; 53():145-58. PubMed ID: 13921595
    [No Abstract] [Full Text] [Related]

  • 38. [Experimental research on the methodology of properdin determination].
    MEINICKE K, SCHREIBER F.
    Hautarzt; 1961 Sep 01; 12():402-10. PubMed ID: 14472235
    [No Abstract] [Full Text] [Related]

  • 39. [On the determination of so-called "available properdin" in human serum].
    von GRAEVENITZ.
    Arztl Forsch; 1960 Mar 10; 14():I/134-6. PubMed ID: 13855870
    [No Abstract] [Full Text] [Related]

  • 40. [Studies on quantitative serum properdin determination].
    KOEGLER W, SCHEIFFARTH F, FRENGER W.
    Acta Haematol; 1961 Jan 10; 25():49-55. PubMed ID: 13757431
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.